AJMC in the Press, August 19, 2016

A review of coverage of our peer-reviewed research, in the mainstream and healthcare press.

Two articles in the new issue of The American Journal of Managed Care are gaining notice in the healthcare press this week. David Salazar of DrugStore News was among those who wrote about “The Impact of Formulary Drug Exclusion Policies on Patients and Heatlhcare Costs,” which is a review 26 studies. The article, by researchers at the Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies, in the Center for the Evaluation of Value and Risk in Health, found that while there are exceptions, most research shows that exclusions save money without harming patients.

The article, “Opinions on the Hospital Readmission Reduction Program: Results of a National Survey of Hospital Leaders,” drew plenty of reader and press interest. Jacqueline Belliveau of RevenueCycle Intelligence covered the results of the survey, which found that two-thirds of respondents feel CMS’ financial penalties for not meeting 30-day readmission targets are having a major effect on their efforts to decrease readmissions. The authors, from Harvard’s T.H. Chan School of Public Health, also found that three-quarter of the leaders faulted CMS for failing to account for differences in the socioeconomic mix of hospital populations.

Related Videos
Screenshot of Eleonora Lad, MD, PhD, smiling
Davey B. Daniel, MD, Chief Medical Officer, OneOncology
Debra Patt, MD, PhD, MBA, Executive Vice President, Texas Oncology
Michael Burger
Jeffrey Casberg
Amy Valley, Vice President for Clinical Strategy and Technology Solutions, Cardinal Health
Ben Jones, Vice President of Government Relations and Public Policy, US Oncology Network
Yuqian Liu, PharmD
Related Content
© 2023 MJH Life Sciences
All rights reserved.